Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:5/5/2014
Start Date:December 2013
End Date:December 2014

Use our guide to learn which trials are right for you!

The primary objective is to evaluate the impact on heart failure related quality of life
when integrating a mobile health system, Verizon Wireless's Converged Health Management
(CHM), into a subject's self-management of their heart failure (HF) as well as in the
medical management of HF by the subjects' clinical team.


Inclusion Criteria:

1. Adult (≥ 18 years of age)

2. A least 1 prior hospitalization within the past 12 months for HF based upon the
presence of at least 1 symptom (dyspnea, orthopnea, or edema) AND at least 1 sign
(rales, peripheral edema, ascites, or pulmonary vascular congestion on chest
radiography)AND treatment with a loop diuretic during the hospital stay OR Symptoms
of New York Hospital Association (NYHA) Class 2+ symptoms: dyspnea, fatigue, or
chest pain with normal physical activity (class II), less than ordinary activity
(class III) or at rest (class IV).

Information may be provided by subject self-report obtained during the initial
screening process and/or by medical record confirmation. Compliance with all
eligibility criteria will be confirmed at the initial study visit before subject is
presented with the ICF.

3. Receiving care at the SMH HF Clinic and assessed by the clinic at least twice.
(Those who were seen in person on their first visit and then followed-up by telephone
thereafter will be considered eligible).

4. Able to provide contact information for someone who agrees to provide information
about the subject if the subject is not available to do so.

5. Capability of understanding and willingness to comply with the protocol and study
requirements, assessed according to the Principal Investigator's judgment.

6. Ability to understand and willingness to sign a written informed consent document,
assessed according to the Principal Investigator's judgment.

Exclusion Criteria:

1. Decline to participate in the study

2. Reside in an area with limited to no Verizon Wireless coverage as determined by VZ
using the VZ zip code coverage analysis technology.

3. Scheduled procedure for left ventricular device implantation, or listed for potential
cardiac transplant

4. Current resident of a long-term care or skilled nursing facility

5. Currently receiving palliative or hospice care

6. Human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS)
based on past medical history or subject self-report

7. Dialysis-dependent, end-stage renal disease

8. A concurrent physical condition (including rare or chronic diseases such as sickle
cell anemia or cystic fibrosis) or mental health condition (including dementia,
schizophrenia, or other mental illness) that in the view of the Principal
Investigator would compromise the subject's ability to fulfill the protocol
requirements or affect the subject's safety during the study

9. Are unable or unwilling to comply with the study requirements as instructed including
coming to the SMH HF clinic for the 2 study visits.

10. For subjects in the Intervention Group that are:

1. Unable or unwilling to return to the SMH clinic to receive their training,
devices and study material after signing the informed consent form and being
randomized into the Intervention Group;

2. Unable or unwilling to use the biometric devices and CHM at least one time per
day.

11. Are pregnant or planning to become pregnant during the study.

-
We found this trial at
1
site
?
mi
from
Sarasota, FL
Click here to add this to my saved trials